102 related articles for article (PubMed ID: 3395395)
1. Studies on the nonspecific central nervous system effects of the novel antitussive compound vadocaine hydrochloride.
Karttunen P; Männistö PT; Lahovaara S; Havas A
Arzneimittelforschung; 1988 Apr; 38(4A):605-8. PubMed ID: 3395395
[TBL] [Abstract][Full Text] [Related]
2. Antitussive action of the new anilide derivative vadocaine hydrochloride compared with codeine phosphate in four animal models.
Männistö PT; Karttunen P; Lahovaara S; Nissinen E; Davies JE; Algate DR; Baines MW
Arzneimittelforschung; 1988 Apr; 38(4A):598-604. PubMed ID: 3395394
[TBL] [Abstract][Full Text] [Related]
3. Comparative studies on the dependence liability of morphine hydrochloride, codeine phosphate and two novel antitussive compounds vadocaine hydrochloride and N-(2',4'-dimethyl-6'-methoxyphenyl)-4-(diethylamine) butanamide hydrochloride in mice.
Etemadzadeh E; Ahtee L; Männistö PT
Arzneimittelforschung; 1988 Apr; 38(4A):620-3. PubMed ID: 3395398
[TBL] [Abstract][Full Text] [Related]
4. First human studies on the safety and antitussive activity of vadocaine hydrochloride.
Karttunen P; Tukiainen H; Uusitupa M; Männistö PT
Arzneimittelforschung; 1988 Apr; 38(4A):631-4. PubMed ID: 3395401
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular and ventilator effects of vadocaine hydrochloride in urethane-anaesthetized rats and guinea-pigs.
Paakkari I; Svartström-Fraser M
Arzneimittelforschung; 1988 Apr; 38(4A):617-9. PubMed ID: 3395397
[TBL] [Abstract][Full Text] [Related]
6. Assessment of the antitussive effect of vadocaine hydrochloride using citric acid-induced cough in healthy volunteers.
Karttunen P
Arzneimittelforschung; 1988 Apr; 38(4A):639-41. PubMed ID: 3395403
[TBL] [Abstract][Full Text] [Related]
7. Tissue distribution of the novel antitussive compound vadocaine hydrochloride in white female mice studied by whole-body autoradiography.
Vuorela A; Mäntylä R; Männistö PT
Arzneimittelforschung; 1988 Apr; 38(4A):628-30. PubMed ID: 3395400
[TBL] [Abstract][Full Text] [Related]
8. Effects of lidocaine, codeine and vadocaine hydrochloride on platelet aggregation in human platelet-rich plasma.
Kangasaho M
Arzneimittelforschung; 1988 Apr; 38(4A):613-6. PubMed ID: 2840087
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the effects of two opioid antitussives, vadocaine hydrochloride, clobutinol and lidocaine on lung mechanics in guinea-pigs.
Salonen RO
Arzneimittelforschung; 1988 Apr; 38(4A):609-12. PubMed ID: 3395396
[TBL] [Abstract][Full Text] [Related]
10. Assessment of the safety margin of vadocaine hydrochloride in man.
Karttunen P; Uusitupa M; Helin M; Tukiainen H; Silvasti M
Arzneimittelforschung; 1988 Apr; 38(4A):642-6. PubMed ID: 3395404
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of graded single doses of the novel antitussive compound vadocaine hydrochloride in healthy male volunteers.
Karttunen P; Männistö PT; Tukiainen H; Uusitupa M; Nissinen E
Arzneimittelforschung; 1988 Apr; 38(4A):635-8. PubMed ID: 3395402
[TBL] [Abstract][Full Text] [Related]
12. Preliminary pharmacokinetics of the new antitussive compound vadocaine hydrochloride in animals.
Mäntylä R; Männistö PT; Vuorela A; Nissinen E
Arzneimittelforschung; 1988 Apr; 38(4A):624-7. PubMed ID: 3395399
[TBL] [Abstract][Full Text] [Related]
13. Steady state pharmacokinetics of the new antitussive compound vadocaine hydrochloride.
Silvasti M; Karttunen P; Tukiainen H; Mykkänen M; Ottoila P
Arzneimittelforschung; 1990 Apr; 40(4):453-6. PubMed ID: 2357246
[TBL] [Abstract][Full Text] [Related]
14. The single dose and steady-state pharmacokinetics of a vadocaine tablet in healthy human volunteers.
Silvasti M; Karttunen P; Tukiainen H; Mykkänen M; Hänninen U; Välttilä S
Int J Clin Pharmacol Ther Toxicol; 1989 Nov; 27(11):558-63. PubMed ID: 2613390
[TBL] [Abstract][Full Text] [Related]
15. General pharmacological properties of a new non-opiate antitussive: zipeprol (3024 CERM). II. Actions on the cardiovascular system, intestinal transit and central nervous system.
Cosnier D; Hache J; Labrid C; Rispat G
Arzneimittelforschung; 1976; 26(5):848-55. PubMed ID: 989357
[TBL] [Abstract][Full Text] [Related]
16. Central action of glucagon.
Morawska D; Sieklucka-Dziuba M; Kleinrok Z
Pol J Pharmacol; 1998; 50(2):125-33. PubMed ID: 9798264
[TBL] [Abstract][Full Text] [Related]
17. [General pharmacologic studies on the analgesic flupirtine].
Jakovlev V; Achterrath-Tuckermann U; von Schlichtegroll A; Stroman F; Thiemer K
Arzneimittelforschung; 1985; 35(1):44-55. PubMed ID: 4039152
[TBL] [Abstract][Full Text] [Related]
18. Pharmacology of amezinium, a novel antihypotensive drug. VI. Effect on central nervous functions.
Teschendorf HJ; Kretzschmar R; Kreiskott H; Weifenbach H
Arzneimittelforschung; 1981; 31(9a):1580-8. PubMed ID: 7197973
[TBL] [Abstract][Full Text] [Related]
19. General pharmacology of beraprost sodium. 1st communication: effect on the central nervous system.
Murata T; Sakaya S; Hoshino T; Umetsu T; Hirano T; Nishio S
Arzneimittelforschung; 1989 Aug; 39(8):860-6. PubMed ID: 2510742
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological studies of mabuterol, a new selective beta 2-stimulant. III: Effects on the central nervous system, striated muscle and carbohydrate and lipid metabolism.
Osada E; Sakaya S; Sanai K; Seri K
Arzneimittelforschung; 1984; 34(11A):1652-8. PubMed ID: 6152158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]